at CNBC.com (Sep 26, 2013)
Onyx Pharmaceuticals (ONXX) announces a 4.4M share secondary offering with a 30-day option to...
Onyx Pharmaceuticals (ONXX) announces a 4.4M share secondary offering with a 30-day option to purchase up to an additional 660K shares to cover over-allotments, if any. The offering is expected to close by January 22, 2013, and the company intends to use the net proceeds to fund its clinical development programs, R&D, and sales and marketing activities to globally commercialize Kyprolis. BofA Merrill Lynch and Barclays are co-book runners. Shares -2% AH.
From other sites
at Fox Business (Sep 19, 2013)
at CNBC.com (Aug 27, 2013)
at CNBC.com (Aug 26, 2013)
at MarketWatch.com (Aug 26, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs